The chemical class of HXK III Activators comprises compounds that indirectly influence Hexokinase III activity through various cellular mechanisms. These chemicals do not directly bind or interact with HXK III but modulate its activity by affecting cellular conditions, substrate levels, or related signaling pathways. For instance, compounds like AICAR and insulin mimetics alter metabolic enzyme phosphorylation or glucose metabolism, respectively, thereby modulating HXK III's activity indirectly. Berberine, by enhancing glucose uptake, increases the substrate available for HXK III, a key enzyme in glycolysis.
Other compounds in this class, such as 2,4-Dinitrophenol and Vanadyl Sulfate, exert their effects through modulating energy demands or mimicking hormonal signals, which in turn impacts glycolytic activity and HXK III. Lithium Chloride and Trifluoperazine represent another aspect of this class, influencing HXK III through their effects on signaling pathways like GSK-3 inhibition or calmodulin antagonism. Additionally, compounds like NECA, Pioglitazone, and Nicotinamide Riboside, through their actions on adenosine receptors, PPAR activation, or NAD+ precursor status, contribute to the nuanced regulation of metabolic pathways that ultimately influence HXK III activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
Activates AMPK, impacting metabolic enzyme phosphorylation, including hexokinases. This modulation potentially alters HXK III activity. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $90.00 | 1 | |
Induces GLUT translocation, enhancing glucose uptake. Elevated intracellular glucose stimulates HXK III as part of glycolysis. | ||||||
2,4-Dinitrophenol, wetted | 51-28-5 | sc-238345 | 250 mg | $58.00 | 2 | |
Uncouples oxidative phosphorylation, raising ATP demand. This upregulates glycolysis, indirectly stimulating HXK III. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
Phosphorylated by hexokinases like HXK III but is non-metabolizable, influencing HXK III activity through feedback mechanisms at specific concentrations. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3, affecting metabolic and glucose pathways, potentially altering HXK III activity. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Activates PI3K, impacting glucose metabolism and potentially HXK III activity. | ||||||
L-Leucine | 61-90-5 | sc-364173 sc-364173A | 25 g 100 g | $21.00 $61.00 | ||
Activates mTOR, a regulator of metabolism, potentially influencing HXK III in a context-dependent manner. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
Activates PPAR, impacting glucose metabolism and fatty acid storage, indirectly modulating HXK III activity. | ||||||
Nicotinamide riboside | 1341-23-7 | sc-507345 | 10 mg | $411.00 | ||
As an NAD+ precursor, it impacts cellular redox states and metabolism, affecting HXK III activity through metabolic feedback. | ||||||